As American drug companies adjust to an increasingly competitive global marketplace, Katherine A. Helm, a technical advisor to the Fish & Neave IP Group of Ropes & Gray, argues that U.S. patent jurisprudence should embrace – rather than fight – the phenomenon of globalization. In her article, published in the Fordham Intellectual Property, Media & Entertainment Law Journal, Helm examines the various forces faced by drug companies and concludes that the U.S. patent system should allow American pharmaceutical companies to leverage their intangible assets while permitting scientific innovation to advance in the U.S. and throughout the world. To read Helm's article, please click "Download PDF."
Stay Up To Date with Ropes & Gray
Subscribe to Our Podcast
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Follow Us on Social
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
Join Our Mailing List
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.